Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Camargo Pharmaceutical Services
Camargo Pharmaceutical Services
Activities:
Research & Development
Analysis
Cardiovascular
Mental Health
Cognitive
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Schenck Process FPM becomes Coperion
Effective August 1, 2024, the company will officially transition its name under Coperion, whilst also providing more resources and broader technology capabilities to customers
Torbay Pharma strengthens leadership team to support North American growth strategy
The company has welcomed Mohammed Nazir as Chief Operating Officer (COO) and Tara Slivey as Chief Product Officer (CPO)
Ingenza expands codABLE gene design algorithm to aid recombinant protein production in yeast
The codABLE platform can help to accelerate the development and production of proteins in yeast hosts
DevPro Biopharma and Bespak complete early studies for novel sustainable albuterol inhaler
The novel formulation exhibits a low global warming potential (GWP) and shows comparable performance to Ventolin HFA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Regulatory
Two new appointments at Camargo Pharmaceutical Services
VP, Scientific and Regulatory Affairs and Director, Contracts and Legal Projects
Regulatory
Camargo names new Chief Financial Officer
Carter Gaither joins the 505(b)(2) process specialist in Cincinnati, US
Research & Development
Camargo expands research team
Adds four more members of staff
Research & Development
Camargo Pharmaceutical Services names Jim Beach as Chief Operating Officer
He joins the US drug development firm from Cardinal Health
Camargo appoints vice president of drug development
Gary Barnette joins the US firm from GTx
Subscribe now